Monique Van Leerdam
Appearances
- DateMay 9, 2023In the Dutch colorectal cancer (CRC) screening program, individuals aged 55 to 75 years are invited biennially for fecal immunochemical test (FIT)-based screening using a positivity cut-off of 47 microgram Hemoglobin per gram feces (µg Hb/g)…
- DateMay 6, 2023Colonoscopy surveillance intervals are based on the predicted risk of metachronous colorectal cancer (CRC) after polyp removal. Due to the presence of co-existent findings at baseline colonoscopy, risk estimation per specific polyp subtype is difficult…
Presenter
Speakers
Erasmus MCAcademic Medical Center - DateMay 20, 2024Most colorectal cancer (CRC) screening programs use a uniform screening strategy. However, it may be more efficient to screen males and females differently due to (ambivalent) biological and demographic differences between the sexes…
- DateMay 20, 2024Colorectal cancer (CRC) screening programmes have been shown effective in reducing CRC incidence and mortality. Risk stratification offers opportunities for further optimisation of screening programmes by better balancing the harms and benefits of screening…
Presenter
Speakers
- DateMay 19, 2024Colonoscopy surveillance for Lynch syndrome is burdensome and post-colonoscopy colorectal cancers (CRCs) still occur. The non-invasive faecal immunochemical test (FIT) might guide optimal colonoscopy intervals…
- DateMay 20, 2024Colonoscopy surveillance for Lynch syndrome is burdensome and post-colonoscopy colorectal cancer (CRC) still occurs. Non-invasive faecal volatile organic compounds (VOCs) might guide optimal colonoscopy intervals…